315 related articles for article (PubMed ID: 9265864)
41. Future trends in Kaposi's sarcoma and lymphoma.
Schulz TF
Int J STD AIDS; 1998; 9 Suppl 1():32-4. PubMed ID: 9874115
[No Abstract] [Full Text] [Related]
42. Gamma-herpesvirus neoplasia: a growing role for COX-2.
Shelby BD; Nelson A; Morris C
Microsc Res Tech; 2005 Nov; 68(3-4):120-9. PubMed ID: 16276519
[TBL] [Abstract][Full Text] [Related]
43. Kaposi's sarcoma-associated herpesvirus: a new human tumor virus, but how?
Schulz TF; Moore PS
Trends Microbiol; 1999 May; 7(5):196-200. PubMed ID: 10354594
[TBL] [Abstract][Full Text] [Related]
44. Uncommon hematologic malignancies. Case 1. Plasmablastic leukemia in HIV-associated multicentric Castleman's disease.
Jung CP; Horster S; Lohse P; Bogner JR; Emmerich B; Goebel FD
J Clin Oncol; 2003 Nov; 21(22):4248-9. PubMed ID: 14615455
[No Abstract] [Full Text] [Related]
45. Multicentric Castleman's disease in association with Kaposi's sarcoma.
De Rosa G; Barra E; Guarino M; Gentile R
Appl Pathol; 1989; 7(2):105-10. PubMed ID: 2730798
[TBL] [Abstract][Full Text] [Related]
46. Regulation of growth signalling and cell cycle by Kaposi's sarcoma-associated herpesvirus genes.
Direkze S; Laman H
Int J Exp Pathol; 2004 Dec; 85(6):305-19. PubMed ID: 15566428
[TBL] [Abstract][Full Text] [Related]
47. Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology and Molecular Biology.
Li S; Bai L; Dong J; Sun R; Lan K
Adv Exp Med Biol; 2017; 1018():91-127. PubMed ID: 29052134
[TBL] [Abstract][Full Text] [Related]
48. [Human herpesvirus 8 (HHV8). II. Pathogenic role and sensitivity to antiviral drugs].
Boulanger E
Ann Biol Clin (Paris); 1999; 57(1):19-28. PubMed ID: 9920963
[TBL] [Abstract][Full Text] [Related]
49. Human herpesvirus 8: biology and role in the pathogenesis of Kaposi's sarcoma and other AIDS-related malignancies.
Viejo-Borbolla A; Ottinger M; Schulz TF
Curr HIV/AIDS Rep; 2004 Apr; 1(1):5-11. PubMed ID: 16091217
[TBL] [Abstract][Full Text] [Related]
50. Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Renders B Cells Hyperresponsive to Secondary Infections.
Sin SH; Eason AB; Bigi R; Kim Y; Kang S; Tan K; Seltzer TA; Venkataramanan R; An H; Dittmer DP
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021906
[TBL] [Abstract][Full Text] [Related]
51. Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient.
Murphy C; Hawkes E; Chionh F; Chong G
J Clin Pharm Ther; 2017 Feb; 42(1):111-114. PubMed ID: 27790727
[TBL] [Abstract][Full Text] [Related]
52. Variability and evolution of Kaposi's sarcoma-associated herpesvirus in Europe and Africa. International Collaborative Group.
Cook PM; Whitby D; Calabro ML; Luppi M; Kakoola DN; Hjalgrim H; Ariyoshi K; Ensoli B; Davison AJ; Schulz TF
AIDS; 1999 Jul; 13(10):1165-76. PubMed ID: 10416519
[TBL] [Abstract][Full Text] [Related]
53. Can plasma HHV8 viral load be used to differentiate multicentric Castleman disease from Kaposi sarcoma?
Sayer R; Paul J; Tuke PW; Hargreaves S; Noursadeghi M; Tedder RS; Grant P; Edwards SG; Miller RF
Int J STD AIDS; 2011 Oct; 22(10):585-9. PubMed ID: 21998180
[TBL] [Abstract][Full Text] [Related]
54. Corrected prevalence of Kaposi's sarcoma (KS)-associated herpesvirus infection prior to onset of KS.
Parry JP; Moore PS
AIDS; 1997 Jan; 11(1):127-8. PubMed ID: 9110091
[No Abstract] [Full Text] [Related]
55. Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis.
Schulz TF; Cesarman E
Curr Opin Virol; 2015 Oct; 14():116-28. PubMed ID: 26431609
[TBL] [Abstract][Full Text] [Related]
56. Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus.
Aresté C; Blackbourn DJ
Trends Microbiol; 2009 Mar; 17(3):119-29. PubMed ID: 19230674
[TBL] [Abstract][Full Text] [Related]
57. [Human herpesvirus 8 and associated diseases: Kaposi's sarcoma, body cavity based lymphoma and multicentric Castleman disease: clinical and molecular epidemiology].
Gessain A
Bull Acad Natl Med; 1997; 181(6):1023-34. PubMed ID: 9453829
[TBL] [Abstract][Full Text] [Related]
58. Virology, pathogenetic mechanisms, and associated diseases of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8).
Sarid R; Klepfish A; Schattner A
Mayo Clin Proc; 2002 Sep; 77(9):941-9. PubMed ID: 12233927
[TBL] [Abstract][Full Text] [Related]
59. Conservation of virally encoded microRNAs in Kaposi sarcoma--associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease.
Marshall V; Parks T; Bagni R; Wang CD; Samols MA; Hu J; Wyvil KM; Aleman K; Little RF; Yarchoan R; Renne R; Whitby D
J Infect Dis; 2007 Mar; 195(5):645-59. PubMed ID: 17262705
[TBL] [Abstract][Full Text] [Related]
60. KSHV and Kaposi's sarcoma: the end of the beginning?
Ganem D
Cell; 1997 Oct; 91(2):157-60. PubMed ID: 9346233
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
